Synthekine Appoints Geoff Nosrati, Ph.D., as Chief Business Officer and Announces Executive Leadership Changes
Position
Chief Scientific Officer
Company
Synthekine
Menlo ParkBiotechnologyHealth CareTherapeuticsDescription
Synthekine Inc announced the appointment of Geoff Nosrati as chief business officer. Martin Oft assumed the role of chief scientific officer and Greg Yedinak was promoted to chief technical officer.
Quick answer
Synthekine Appoints Geoff Nosrati, Ph.D., as Chief Business Officer and Announces Executive Leadership Changes (February 21, 2024). Synthekine is based in Menlo Park, California, United States.
- What did Synthekine announce on February 21, 2024?
- Synthekine Inc announced the appointment of Geoff Nosrati as chief business officer. Martin Oft assumed the role of chief scientific officer and Greg Yedinak was promoted to chief technical officer.
- What does Synthekine do?
- Synthekine Inc. is an engineered cytokine therapeutics company dedicated to developing novel immunotherapies for cancer and inflammatory diseases.
- Where is Synthekine based?
- Synthekine is based in Menlo Park, California, United States.
- Which similar companies made leadership changes around the same time?
- Jazz Pharmaceuticals plc (February 21, 2024), Paratus Sciences Corporation (February 21, 2024), Ikena Oncology (February 21, 2024) and Arvinas (February 20, 2024) also announced leadership changes within 45 days of Synthekine.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Jazz Pharmaceuticals Appoints Philip Johnson as Chief Financial Officer (February 21, 2024)
- Paratus Sciences Appoints Theresa Heah, M.D., M.B.A. as Chief Executive Officer (February 21, 2024)
- Ikena Oncology Appoints Caroline Germa, M.D. as Chief Medical Officer (February 21, 2024)
- Arvinas Announces Chief Financial Officer Transition (February 20, 2024)
- AbbVie Announces Appointment of Robert A. Michael as Chief Executive Officer (February 20, 2024)
- Evan Ballantyne to join Hansa Biopharma as Chief Financial Officer (February 22, 2024)
Who to call at Synthekine, and when
A new leader at Synthekine brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Synthekine raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Synthekine, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Synthekine. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Synthekine changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Synthekine changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.